{"id":"W2518422528","doi":"10.1634/theoncologist.2016-0164","title":"Monitoring and Management of Immune-Related Adverse Events Associated With Programmed Cell Death Protein-1 Axis Inhibitors in Lung Cancer","year":2016,"lang":"en","type":"review","venue":"The Oncologist","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Pembrolizumab; Nivolumab; Adverse effect; Tolerability; Lung cancer; Oncology; Chemotherapy; Immune system; Immunotherapy; Monoclonal antibody; Internal medicine; Intensive care medicine; Immunology; Antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006536128,0.0004627915,0.001006531,0.001486192,0.0001777451,0.0006458616,0.0005017051,0.000692711,0.00180721],"category_scores_gemma":[0.001005094,0.0001466125,0.0005977255,0.001011978,0.000210829,0.0007304122,0.000414963,0.001082616,0.0007795049],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003421171,"about_ca_system_score_gemma":0.0007444832,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006497087,"about_ca_topic_score_gemma":0.001625981,"domain_scores_codex":[0.9997327,0.00006588586,0.00005351754,0.00002640845,0.0001062007,0.00001534746],"domain_scores_gemma":[0.9996127,0.0001709644,0.0000868249,0.000007762715,0.0001022473,0.00001944201],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005327542,0.00004946474,0.0003295522,0.01728995,0.0001292506,0.000202307,0.00005072302,0.0002278398,0.000803404,0.0009479856,0.01628488,0.9636314],"study_design_scores_gemma":[0.00005541884,0.0002495512,0.002963764,0.01638567,0.0004435928,0.004973788,0.000114267,0.0002501665,0.001101352,0.001880603,0.9715493,0.00003246229],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001680153,0.9987644,0.0001031466,0.0002803022,0.00008947913,0.000005799157,0.00001195045,0.000004616033,0.0005722523],"genre_scores_gemma":[0.001387336,0.9976972,0.0002606972,0.0002049145,0.0001063103,0.000008813629,0.00002420171,0.000001123125,0.000309433],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00180721,"threshold_uncertainty_score":0.006045759,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03120782614683579,"score_gpt":0.3414728858770757,"score_spread":0.3102650597302399,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}